دورية أكاديمية
أعرض في EDS

Drug Inducible CRISPR/Cas Systems.

التفاصيل البيبلوغرافية
العنوان: Drug Inducible CRISPR/Cas Systems.
المؤلفون: Zhang J; School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China., Chen L; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Zhang J; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Wang Y; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China.
المصدر: Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2019 Jul 30; Vol. 17, pp. 1171-1177. Date of Electronic Publication: 2019 Jul 30 (Print Publication: 2019).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology Country of Publication: Netherlands NLM ID: 101585369 Publication Model: eCollection Cited Medium: Print ISSN: 2001-0370 (Print) Linking ISSN: 20010370 NLM ISO Abbreviation: Comput Struct Biotechnol J Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology
Original Publication: Gothenburg, Sweden : Research Network of Computational and Structural Biotechnology
مستخلص: Clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) systems have been employed as a powerful versatile technology for programmable gene editing, transcriptional modulation, epigenetic modulation, and genome labeling, etc. Yet better control of their activity is important to accomplish greater precision and to reduce undesired outcomes such as off-target events. The use of small molecules to control CRISPR/Cas activity represents a promising direction. Here, we provide an updated review on multiple drug inducible CRISPR/Cas systems and discuss their distinct properties. We arbitrarily divided the emerging drug inducible CRISPR/Cas systems into two categories based on whether at transcription or protein level does chemical control occurs. The first category includes Tet-On/Off system and Cre-dependent system. The second category includes chemically induced proximity systems, intein splicing system, 4-Hydroxytamoxifen-Estrogen Receptor based nuclear localization systems, allosterically regulated Cas9 system, and destabilizing domain mediated protein degradation systems. Finally, the advantages and limitations of each system were summarized.
Competing Interests: We declare a conflict of interest associated with this paper: J.Z. and Y. W. have pursued a patent position on the invention of multiple HIT systems of drug inducible CRISPR or TALE(N).
References: Cell. 2015 Aug 27;162(5):1113-26. (PMID: 26317473)
Nat Rev Mol Cell Biol. 2016 Jan;17(1):5-15. (PMID: 26670017)
Nat Commun. 2018 Apr 13;9(1):1466. (PMID: 29654229)
Cell. 2006 Sep 8;126(5):995-1004. (PMID: 16959577)
Stem Cell Reports. 2015 Sep 8;5(3):448-59. (PMID: 26352799)
Cell Stem Cell. 2014 Aug 7;15(2):215-226. (PMID: 24931489)
Chem Biol. 2011 May 27;18(5):619-30. (PMID: 21609843)
J Am Chem Soc. 2015 Feb 18;137(6):2155-8. (PMID: 25647354)
Nat Commun. 2016 Oct 03;7:13056. (PMID: 27694915)
Nat Commun. 2017 Feb 22;8:14370. (PMID: 28224990)
Nat Biotechnol. 2016 Jun;34(6):646-51. (PMID: 27136077)
Nucleic Acids Res. 1996 Apr 15;24(8):1404-11. (PMID: 8628671)
Nat Commun. 2017 Jul 13;8:15993. (PMID: 28703221)
Cell Rep. 2015 Mar 3;10(8):1422-32. (PMID: 25732831)
Nucleic Acids Res. 1996 Oct 1;24(19):3875-7. (PMID: 8871571)
Nucleic Acids Res. 1999 Nov 15;27(22):4324-7. (PMID: 10536138)
Biochem Biophys Res Commun. 1997 Aug 28;237(3):752-7. (PMID: 9299439)
Nat Methods. 2013 Oct;10(10):973-6. (PMID: 23892895)
Sci Signal. 2011 Mar 15;4(164):rs2. (PMID: 21406691)
Nat Biotechnol. 2017 Jun;35(6):569-576. (PMID: 28459449)
Nat Methods. 2015 Apr;12(4):326-8. (PMID: 25730490)
Science. 1996 Jul 12;273(5272):239-42. (PMID: 8662507)
Cell. 2015 Oct 22;163(3):759-71. (PMID: 26422227)
Mol Ther. 2013 Dec;21(12):2169-80. (PMID: 23881415)
Annu Rev Microbiol. 2002;56:263-87. (PMID: 12142479)
Cell. 2015 Jan 15;160(1-2):339-50. (PMID: 25533786)
Nat Plants. 2017 Feb 17;3:17018. (PMID: 28211909)
Chem Biol. 2010 Sep 24;17(9):981-8. (PMID: 20851347)
Nat Biotechnol. 2014 Apr;32(4):347-55. (PMID: 24584096)
Gene Ther. 2006 Oct;13(19):1382-90. (PMID: 16724096)
Nature. 2012 Feb 15;482(7385):331-8. (PMID: 22337052)
J Am Chem Soc. 2015 May 6;137(17):5642-5. (PMID: 25905628)
Nucleic Acids Res. 2001 May 15;29(10):E47. (PMID: 11353092)
Mol Ther Nucleic Acids. 2018 Dec 7;13:208-219. (PMID: 30312845)
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):2984-9. (PMID: 25713377)
Chem Biol. 1994 Nov;1(3):131-6. (PMID: 9383382)
Nat Commun. 2016 Jul 01;7:12009. (PMID: 27363581)
Nat Biotechnol. 2015 Jul;33(7):755-60. (PMID: 26076431)
Science. 2007 Mar 23;315(5819):1709-12. (PMID: 17379808)
Nat Methods. 2013 Nov;10(11):1085-8. (PMID: 24056874)
Nat Chem Biol. 2017 Jan;13(1):9-11. (PMID: 27820801)
Nat Methods. 2016 Oct;13(10):868-74. (PMID: 27595405)
Science. 2010 Jan 8;327(5962):167-70. (PMID: 20056882)
Nat Methods. 2016 Dec;13(12):1043-1049. (PMID: 27776111)
Sci Rep. 2015 Jul 01;5:10777. (PMID: 26126518)
Nucleic Acids Res. 2018 Mar 16;46(5):e25. (PMID: 29237052)
Nature. 2016 Apr 28;532(7600):517-21. (PMID: 27096362)
ACS Chem Biol. 2018 Mar 16;13(3):609-617. (PMID: 29308880)
Science. 2018 Mar 9;359(6380):. (PMID: 29590011)
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6991-5. (PMID: 7624356)
Dev Cell. 2004 Jan;6(1):7-28. (PMID: 14723844)
Cell. 2016 May 5;165(4):949-62. (PMID: 27114038)
Cold Spring Harb Protoc. 2012 Jul 01;2012(7):821-4. (PMID: 22753599)
Nat Biotechnol. 2015 Feb;33(2):139-42. (PMID: 25643054)
Nat Chem Biol. 2015 May;11(5):316-8. (PMID: 25848930)
J Am Chem Soc. 2012 Mar 7;134(9):3942-5. (PMID: 22332638)
Nat Chem Biol. 2016 Nov;12(11):980-987. (PMID: 27618190)
Mol Endocrinol. 1993 Feb;7(2):232-40. (PMID: 8469236)
Curr Biol. 1998 Dec 3;8(24):1323-6. (PMID: 9843687)
Nucleic Acids Res. 2015 Jul 27;43(13):6450-8. (PMID: 26082496)
ACS Chem Biol. 2018 Feb 16;13(2):443-448. (PMID: 28938067)
Chem Biol. 2015 Feb 19;22(2):169-74. (PMID: 25619936)
Cell. 2013 Jul 18;154(2):442-51. (PMID: 23849981)
Nat Med. 2008 Oct;14(10):1123-7. (PMID: 18836461)
Nucleic Acids Res. 1995 May 25;23(10):1686-90. (PMID: 7784172)
Nucleic Acids Res. 2016 Nov 2;44(19):e149. (PMID: 27458201)
Nucleic Acids Res. 1998 Mar 15;26(6):1427-32. (PMID: 9490788)
Cell. 2014 Oct 9;159(2):440-55. (PMID: 25263330)
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18507-12. (PMID: 19017805)
Cell Discov. 2017 Jun 06;3:17018. (PMID: 28607761)
Nat Chem Biol. 2012 Mar 25;8(5):465-70. (PMID: 22446836)
Cell. 2014 Jun 5;157(6):1262-1278. (PMID: 24906146)
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7963-8. (PMID: 10859354)
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4411-6. (PMID: 21368162)
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10505-10. (PMID: 15247421)
Nat Biotechnol. 2015 Apr;33(4):390-394. (PMID: 25690852)
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10887-90. (PMID: 8855277)
Curr Opin Chem Biol. 2015 Oct;28:194-201. (PMID: 26431673)
Annu Rev Biochem. 2000;69:447-96. (PMID: 10966466)
Protein Sci. 2005 Feb;14(2):523-32. (PMID: 15632292)
Nat Methods. 2017 Dec;14(12):1163-1166. (PMID: 29083402)
Gene. 1999 Mar 18;229(1-2):21-9. (PMID: 10095100)
Nat Commun. 2015 Feb 24;6:6256. (PMID: 25708714)
Nat Biotechnol. 2004 Jul;22(7):871-6. (PMID: 15184905)
فهرسة مساهمة: Keywords: 4-OHT, 4-Hydroxytamoxifen; ABA, abscisic acid; ADs, activation domains; CIP, chemically induced proximity; CRISPR, clustered, regularly interspaced, short palindromic repeats; Cas, CRISPR-associated protein; CrRNA, CRISPR RNA; DD, destabilizing domain; DHFR, dihydrofolate reductase; ER, Estrogen Receptor; FKBP, FK506-binding protein; FRB, FKBP-rapamycin-binding domain; GA, gibberellin; HIT, Hybrid drug Inducible CRISPR/Cas9 Technologies; Hsp90, heat shock protein 90; LBD, ligand binding domain; LSL, loxP-stop-loxP; MST, multiplex single transcript; NES, nuclear export sequence; NLS, nuclear localization sequence; Ptet, tetO-containing promoter; Sa, Staphylococcus areus; Sp, Streptococcus pyogenes; TMP, trimethoprim; TRE, tetracycline response element; TRE3G, Tet-On 3G protein; TetO, tet operator; TetR, Tet repressor protein; VPR, VP64-P65-Rta; arC9, allosterically regulated Cas9; dCas9, dead Cas9; dCpf1, dead Cpf1; dLbCpf1, Lachnospiraceae bacterium dCpf1; dox, doxycycline; iPSCs, induced pluripotent stem cells; rtTA, reverse-tTA; sgRNA, single guide RNA
تواريخ الأحداث: Date Created: 20190830 Latest Revision: 20231013
رمز التحديث: 20231013
مُعرف محوري في PubMed: PMC6709367
DOI: 10.1016/j.csbj.2019.07.015
PMID: 31462973
قاعدة البيانات: MEDLINE
الوصف
تدمد:2001-0370
DOI:10.1016/j.csbj.2019.07.015